SCHEMBL839964

SCHEMBL839964

CCOc1cc(-c2ccc(Cl)cc2)nc(CC)c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 1/20 0.49
FABP4 P15090 1/20 0.49
FABP5 Q01469 1/20 0.49
DHODH Q02127 3/20 0.45
CTRC Q99895 3/20 0.44
KDM4E B2RXH2 5/20 0.44
ALDH1A1 P00352 4/20 0.44
HPGD P15428 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
PDE4A P27815 1/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44
RAB9A P51151 1/20 0.44
TP53 P04637 1/20 0.42
HSD17B10 Q99714 2/20 0.41
PTGES O14684 1/20 0.41
ALOX5 P09917 1/20 0.41
CYP2C9 P11712 1/20 0.41
CASP7 P55210 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL831113 0.99 FABP3 (0.48) FABP3FABP4FABP5DHODHCTRC
SCHEMBL830689 0.88 MAPT (0.44) KDM4EALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL831114 0.88 ALDH1A1 (0.39) FABP3FABP4FABP5DHODHCTRC
SCHEMBL831049 0.85 FABP3 (0.47) FABP3FABP4FABP5DHODHCTRC
SCHEMBL832002 0.83 FABP3 (0.45) FABP3FABP4FABP5DHODHCTRC
SCHEMBL831704 0.82 FABP3 (0.44) FABP3FABP4FABP5DHODHCTRC
SCHEMBL17941947 0.77 NAMPT (0.53) DHODH
SCHEMBL831048 0.77 FABP3 (0.46) FABP3FABP4FABP5DHODHCTRC
SCHEMBL831705 0.74 ALDH1A1 (0.39) FABP3FABP4FABP5DHODHCTRC
SCHEMBL829901 0.74 MAPT (0.43) CTRCKDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143411-B2 Substituted 6-phenylnicotinic acids and their use BAYER ANIMAL HEALTH GMBH (DE) 2012-03-27 US disclosed
US-20100234432-A1 Substituted 6-phenylnicotinic acids and their use BAYER ANIMAL HEALTH GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234432-A1 Substituted 6-phenylnicotinic acids and their use SLC5A6, FABP3, NAPRT FABP3 2/4885FABP4 183/4885FABP5 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.